Overview
Erdheim-Chester disease (ECD) is a rare form of non-Langerhans cell histiocytosis characterized by multisystem involvement, commonly presenting with bone pain and extraskeletal manifestations 13.Diagnosis
Clinical features include symmetrical long bone pain, osteosclerotic lesions, xanthelasma, exophthalmos, and interstitial lung disease 3.
Histopathologic confirmation required with tissue biopsies showing histiocytes lacking Langerhans cell markers 3.
Differential diagnosis includes Langerhans cell histiocytosis, metabolic disorders, malignancies, and sarcoidosis 3.Management
First-line treatment: Interferon alpha has been used, though efficacy can be limited as evidenced by progression despite treatment 1.
Adjunctive treatments: Palliative external beam radiotherapy (EBRT) provides short-term relief for symptoms like bone pain, brain infiltration, and retro-orbital involvement 2.
Specific interventions: No specific dosing mentioned beyond interferon alpha use 1.Special Populations
Comorbidities: No specific guidance provided for comorbidities in the given abstracts 123.Key Recommendations
Confirm diagnosis through histopathologic examination of involved tissues showing non-Langerhans cell histiocytes (Evidence: Moderate 3).
Consider palliative EBRT for symptomatic relief in cases of bone pain, brain, or retro-orbital involvement (Evidence: Weak 2).
Interferon alpha may be used as a first-line treatment, though its efficacy in preventing disease progression is limited (Evidence: Weak 1).References
1 Nakhleh A, Slobodin G, Elias N, Bejar J, Odeh M. Rapid progression to cardiac tamponade in Erdheim-Chester disease despite treatment with interferon alpha. Modern rheumatology 2016. link
2 Miller RC, Villà S, Kamer S, Pasquier D, Poortmans P, Micke O et al.. Palliative treatment of Erdheim-Chester disease with radiotherapy: a Rare Cancer Network study. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006. link
3 Shamburek RD, Brewer HB, Gochuico BR. Erdheim-Chester disease: a rare multisystem histiocytic disorder associated with interstitial lung disease. The American journal of the medical sciences 2001. link